Our top pick for
US stocks

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Estia Health is a medical care facilities business based in Australia. Estia Health shares (EHE) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Estia Health has a trailing 12-month revenue of around $665.4 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
Long-term investing
Our top pick for
Low-cost broker
52-week range | $1.88 - $2.5726 |
---|---|
50-day moving average | $2.1723 |
200-day moving average | $2.1937 |
Target price | $2.55 |
PE ratio | 154.6154 |
Dividend yield | $0.046 (2.36%) |
Earnings per share (TTM) | $0.013 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$2.05
1 week (2022-06-22) | 7.33% |
---|---|
1 month (2022-05-27) | -5.53% |
3 months (2022-03-29) | -12.39% |
6 months (2021-12-29) | -9.69% |
1 year (2021-06-29) | -17.00% |
---|---|
2 years (2020-06-29) | 34.43% |
3 years (2019-06-28) | -22.35% |
5 years (2017-06-29) | -34.92% |
Valuing Estia Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Estia Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Estia Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 155x. In other words, Estia Health shares trade at around 155x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Estia Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $114.2 million (£0.0 million).
The EBITDA is a measure of a Estia Health's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $665.4 million |
---|---|
Operating margin TTM | 8.4% |
Gross profit TTM | $141.1 million |
Return on assets TTM | 1.88% |
Return on equity TTM | 0.58% |
Profit margin | 0.52% |
Book value | 2.294 |
Market capitalisation | $525.5 million |
TTM: trailing 12 months
Dividend payout ratio: 66.43% of net profits
Recently Estia Health has paid out, on average, around 66.43% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.36% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Estia Health shareholders could enjoy a 2.36% return on their shares, in the form of dividend payments. In Estia Health's case, that would currently equate to about A$0.046 per share.
Estia Health's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 25 February 2022 (the "ex-dividend date").
Over the last 12 months, Estia Health's shares have ranged in value from as little as $1.88 up to $2.5726. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Estia Health's is 1.2479. This would suggest that Estia Health's shares are a little bit more volatile than the average for this exchange and represent, relatively speaking, a slightly higher risk (but potentially also market-beating returns).
Estia Health Limited provides services in residential aged care homes in Australia. It operates residential aged care homes. As of June 30, 2021, the company had 69 residential aged care homes of which 62 are freehold sites that include 6,289 operational bed licenses in New South Wales, Queensland, South Australia, and Victoria. Estia Health Limited was founded in 2005 and is based in Sydney, Australia.
Everything we know about the Australia Sunny Glass Group IPO, plus information on how to buy in.
Steps to owning and managing Kincora Copper shares.
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
Steps to owning and managing Arcadia Minerals shares.
Steps to owning and managing Nexgen Energy shares.
Steps to owning and managing Keypath Education shares.
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
Steps to owning and managing EBR Systems shares.
Steps to owning and managing 5E Advanced Materials shares.